Oppenheimer raised the firm's price target on IFF to $90 from $88 and keeps an Outperform rating on the shares. The firm notes IFF delivered a strong Q1, providing a buffer against the uncertain macro backdrop ahead, maintaining its FY26 guide. While Oppenheimer expects demand will continue to dictate shares' performance, the firm sees the impending update on Food Ingredients as a key catalyst over the coming quarter, capping a years-long emphasis on rightsizing the portfolio and balance sheet.
